| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Stocks Mutual Funds > Commodity Futures and Options Trading- Money Management, Risk and Trading Logic, PART 4 |
|
Top Articles - Commodity Futures and Options Trading- Money Management, Risk and Trading Logic, PART 4
Possibly the most important aspect to get right in trading is survival. This is number one. Without surviving the bad times we are gone, with no hope. Money management and r According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product isk may sound like boring subjects, but read on to see how exciting they can be once you learn the concrete reasons and logic for their use. You may never trade the same way ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in again! There are commodity futures and option traders who make multi-millions every year. Some have been known to earn several hundred million a year. They consistently ma lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e a great living, to say the least. And there are traders who consistently lose. Commodity trading is a big arena, just like the stock market. I used to wonder why the CFTC here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe didn't come down hard on commodity firms and brokers who consistently lost money for clients. I thought that if it was any other kind of business, wouldn’t the consumer pro d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ection or some government authority shut them down? Then it dawned on me. This is a zero sum game! It's actually a negative sum game when commissions and so called “exchang ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc e, transaction, etc." fees are added in. For every commodity trader long there is someone short. For every winning uptick for one trader, there is a losing uptick for someon easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi else. So this means that half of the money must be lost by somebody if half are winners. Or 95% of the money is lost by commodity traders who give it to 5% of the prospero nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically us others. With a zero sum game, there MUST be many losers, and some big losers if there are big winners. If the CFTC did an audit of a commodity brokerage firm, they could and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ell EXPECT to come in and find brokers with customer accounts that are doing poorly. Brokerage commissions and profits won by the best traders must come from somewhere. Thi ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s is normal and the way the futures markets (and stock markets to some degree) have worked for over a century. As long as everything was done legally and ethically, there is ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a no problem with customers losing. There is always a winner and loser in commodities. The same with Las Vegas. Vegas is also a negative sum game, given the house odds. The c dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sino house is equivalent to the best commodity traders. (and brokerage houses, of course) Interestingly enough, theoretically, an exception is the stock market. You could h cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ave 100% winning traders if everyone were long and all the stocks kept going up. Even the commissions could be covered. But this is never the case in the real world. There i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen probably no difference in losing statistics for stock or commodity speculators. It’s a strange arena, this trading. You simply must remember that it is YOU against the comp t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel etition. And there are sharp traders out there. Pure capitalism. You must make it as difficult as possible for them to take your commodity account money away. Bottom line: ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust hen your commodity trading method’s accuracy is low by design, you MUST let your profits run bigger than losses and limit your losses in order to be profitable to survive ov y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products er the long haul. You should also never risk more than 5% to 7.5% on any one trade. When trading accuracy is high by design, you can then let the profit to loss ratio get cl . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ser to 1:1, take quicker profits and slower losses and risk up to 10% a trade. Remember that your goal is eventually to risk 5% or less a trade, as many professionals do. F elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ive of Five Parts - Next! There is substantial risk of loss trading futures and options and may not be suitable for all types of investors. Only risk capital should be used tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Leadership Marketing - Free Marketing Lessons Web Marketing For Small Business Enhance Your Home With Secured Home Improvement Loan
|